What is Elaborate?
Founded in 2021, Elaborate operates at the intersection of clinical diagnostics and patient engagement. The company provides a sophisticated platform that integrates directly with Electronic Medical Records (EMR) systems to synthesize laboratory results into personalized, easy-to-understand reports. By leveraging a proprietary clinical insights engine, Elaborate empowers healthcare practitioners to deliver high-value, context-rich summaries that explain not only what the data indicates but also the recommended next steps for patient care. This approach addresses a critical inefficiency in modern healthcare, where raw data often lacks the narrative clarity required for effective patient management and adherence to treatment protocols.
How much funding has Elaborate raised?
Elaborate has raised a total of $10M across 1 funding round:
Angel/Seed
$10M
Angel/Seed (2023): $10M with participation from Founder Collective and Company Ventures
Key Investors in Elaborate
Founder Collective
A venture capital fund focused on seed and pre-seed investments, partnering with entrepreneurs from the idea stage to IPO with a focus on capital efficiency.
Company Ventures
An investment entity associated with high-end commercial development, providing strategic backing to firms operating within the New York innovation ecosystem.
What's next for Elaborate?
With this major enterprise-level funding, Elaborate is poised to scale its operations and deepen its integration capabilities across the broader healthcare ecosystem. The strategic roadmap likely involves expanding its clinical insights engine to cover a wider array of diagnostic specialties and enhancing its EMR interoperability to support larger hospital networks. As the company transitions from its initial development phase to a period of rapid market penetration, the focus will remain on maintaining clinical accuracy while scaling the user experience for both physicians and patients. This capital injection provides the necessary runway to solidify Elaborate's position as a standard-bearer for patient-centric diagnostic communication in the digital health sector.
See full Elaborate company page
